<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>80(12)</volume><submitter>Sousa-Pinto B</submitter><funding>European Academy of Allergy and Clinical Immunology</funding><funding>MASK-air SAS</funding><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Satisfaction with treatments may affect medication adherence and use patterns, including the use of co-medication. We aimed to compare different medications for allergic rhinitis (AR) on (i) patients' satisfaction and (ii) co-medication use frequency.&lt;h4>Methods&lt;/h4>We assessed data from the mHealth app MASK-air. We evaluated days on which users with self-reported AR had used-alone or in co-medication-intranasal corticosteroids (INCS), intranasal antihistamines (INAH), fixed combinations of INAH+INCS, or oral antihistamines (OAH). We built multivariable regression models to compare these different AR medication classes (as well as individual medications) on their (i) treatment satisfaction levels (measured using a specific daily visual analogue scale ['VAS satisfaction</pubmed_abstract><journal>Allergy</journal><pagination>3319-3330</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12666759</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK-air and EAACI Methodological Committee Report.</pubmed_title><pmcid>PMC12666759</pmcid><pubmed_authors>Martini M</pubmed_authors><pubmed_authors>Toppila-Salmi SK</pubmed_authors><pubmed_authors>Vecillas LL</pubmed_authors><pubmed_authors>Klimek L</pubmed_authors><pubmed_authors>Bedbrook A</pubmed_authors><pubmed_authors>Walusiak-Skorupa J</pubmed_authors><pubmed_authors>Regateiro FS</pubmed_authors><pubmed_authors>Zuberbier T</pubmed_authors><pubmed_authors>Czarlewski W</pubmed_authors><pubmed_authors>Niedoszytko M</pubmed_authors><pubmed_authors>Samolinski B</pubmed_authors><pubmed_authors>Thomander T</pubmed_authors><pubmed_authors>Canonica GW</pubmed_authors><pubmed_authors>Fonseca JA</pubmed_authors><pubmed_authors>Gil-Mata S</pubmed_authors><pubmed_authors>Pham-Thi N</pubmed_authors><pubmed_authors>Larenas-Linnemann DE</pubmed_authors><pubmed_authors>Dykewicz M</pubmed_authors><pubmed_authors>Pereira AM</pubmed_authors><pubmed_authors>Marques-Cruz M</pubmed_authors><pubmed_authors>Kvedariene V</pubmed_authors><pubmed_authors>Ivancevich JC</pubmed_authors><pubmed_authors>Ordak M</pubmed_authors><pubmed_authors>Giovannini M</pubmed_authors><pubmed_authors>Sousa-Pinto B</pubmed_authors><pubmed_authors>Papadopoulos NG</pubmed_authors><pubmed_authors>Ventura MT</pubmed_authors><pubmed_authors>Gemicioglu B</pubmed_authors><pubmed_authors>Bonadonna P</pubmed_authors><pubmed_authors>Brussino L</pubmed_authors><pubmed_authors>Schunemann HJ</pubmed_authors><pubmed_authors>Bousquet J</pubmed_authors><pubmed_authors>Paoletti G</pubmed_authors><pubmed_authors>Pfaar O</pubmed_authors><pubmed_authors>Moreira A</pubmed_authors><pubmed_authors>Xiang YK</pubmed_authors><pubmed_authors>di Bona D</pubmed_authors><pubmed_authors>Coutinho-Almeida J</pubmed_authors><pubmed_authors>Bognanni A</pubmed_authors><pubmed_authors>Amaral R</pubmed_authors><pubmed_authors>Koyuncu IV</pubmed_authors><pubmed_authors>Valiulis A</pubmed_authors><pubmed_authors>Taborda-Barata L</pubmed_authors><pubmed_authors>Cruz AA</pubmed_authors><pubmed_authors>Vieira RJ</pubmed_authors><pubmed_authors>Sastre J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK-air and EAACI Methodological Committee Report.</name><description>&lt;h4>Introduction&lt;/h4>Satisfaction with treatments may affect medication adherence and use patterns, including the use of co-medication. We aimed to compare different medications for allergic rhinitis (AR) on (i) patients' satisfaction and (ii) co-medication use frequency.&lt;h4>Methods&lt;/h4>We assessed data from the mHealth app MASK-air. We evaluated days on which users with self-reported AR had used-alone or in co-medication-intranasal corticosteroids (INCS), intranasal antihistamines (INAH), fixed combinations of INAH+INCS, or oral antihistamines (OAH). We built multivariable regression models to compare these different AR medication classes (as well as individual medications) on their (i) treatment satisfaction levels (measured using a specific daily visual analogue scale ['VAS satisfaction</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-06T14:34:59.143Z</modification><creation>2026-05-31T03:09:58.325Z</creation></dates><accession>S-EPMC12666759</accession><cross_references><pubmed>41001805</pubmed><doi>10.1111/all.70055</doi></cross_references></HashMap>